|
May 15, 2026 — FxNutrition Intelligence
Evidence-driven intelligence for functional nutrition practitioners
A Nutrishify publication • Week of May 15, 2026
|
|
This week we’re piloting a faster Evidence Spotlight format: takeaway-first blurbs in plain English, with the journal and date tucked right beside each Read study link—still evidence-grounded, just easier to scan.
Below: iodine and child neurodevelopment, what actually moves stillbirth risk at umbrella-review scale, and why prenatal supplement adherence is often a household project—not a solo willpower problem—plus podcasts, events, and a lighter industry note.
|
|
Evidence Spotlight
|
If you counsel prenatal clients on iodine, the through-line is blunt: kids born to mothers with suboptimal iodine status carried about 19% higher odds of adverse neurodevelopmental outcomes in this pooled analysis of eight cohorts (OR 1.19, 95% CI 1.03–1.39), with cognition drifting the most (Hedges’ g ≈ −0.22). The same paper sketches a plausible dietary neighborhood around 150–300 µg/day from exploratory dose-response work—treat that as directional signal, not a locked guideline, because the curve never crossed conventional significance once cohorts were combined. Read study → ( Nutrients, May 5, 2026)
|
Few interventions reliably move stillbirth risk. This umbrella review of 116 systematic reviews argues balanced energy-protein supplementation is one of the rare levers with a clear mortality-benefit signal—alongside skilled intrapartum care and proactive community health worker visits. Odd twist: trimming antenatal visits below standard-care expectations showed a possible uptick in stillbirth risk, a useful reminder that “less contact” is not automatically safer when you are advising cadence. Read study → ( BMJ Open, May 11, 2026)
|
In rural Bangladesh, whether a woman actually takes her prenatal supplements has less to do with solo motivation and more to do with whether the kitchen table gets it—mothers-in-law, husbands, even kids shaping norms and logistics. Qualitative work nested in the TARGET-BEP trial found active family buy-in tracks with steadier use; neighbors could nudge adherence up or gossip it down. For practice: frame adherence as household coalition-building, not just patient education. Read study → ( BMJ Open, May 12, 2026)
|
|
By The Numbers
19% higher odds
Across eight studies, low maternal iodine was linked to bumpier neurodevelopment, especially in cognition.
|
|
|
Clinical Pearl
The whole ladder mattered.
Nutrition, skilled delivery care, and home visits from community health workers lined up with lower stillbirth risk.
|
|
|
|
Recent Podcasts
|
|
The Estrogen Myth: Rethinking Hormone Therapy & Breast Cancer Risk
The DUTCH Podcast • May 12, 2026
Worth listening if you counsel perimenopausal or postmenopausal clients on hormone therapy decisions. Dr. Jenn Simmons challenges assumptions rooted in the Women’s Health Initiative era—covering the distinction between synthetic progestins and bioidentical progesterone, how estrogen metabolite pathways connect to cancer risk, and what individualized hormone therapy assessment looks like. The conversation includes how DUTCH testing provides context for metabolic risk patterns that standard labs miss. Listen →
|
|
AMA #84: Family health history, preventing heart disease, metabolic health, strength training efficiency, dementia risk reduction, NAD supplements, and hydration
The Peter Attia Drive • May 4, 2026
Useful if you field broad cardiometabolic questions and want a well-reasoned reference point. Peter Attia covers how to use family health history alongside genetic data for risk framing, evidence-efficient strength training approaches, dementia risk reduction priorities, and his current position on NAD precursor supplementation. The episode models how to synthesize evidence across multiple prevention domains at once. Listen →
|
|
Master Self Control & Overcome Procrastination | Dr. Kentaro Fujita
Huberman Lab • May 11, 2026
Relevant if behavior change and dietary adherence support are part of your practice. Andrew Huberman speaks with Dr. Kentaro Fujita, a leading self-control researcher, about how self-control works beyond simple impulse inhibition—including the role of psychological distance, identity-level framing, and intrinsic versus extrinsic motivation. The conversation offers research-grounded vocabulary for client conversations about follow-through and sustainable change. Listen →
|
|
Mark Your Calendar
|
May 15 — Personalized Nutrition for Oncology & Cancer Care Virtual Symposium
Full-day virtual (10AM–5PM ET) | 9.5 AMA PRA Category 1 CE/CME credits — Register →
|
May 14–16 — ECO26 — CellCore 10th Clinical Education Conference
In-person in Boise, ID | Virtual attendance available for May 15–16 — Register →
|
May 19 — Decoding Healthspan: Integrating Genetic Insights for Inflammaging — From Hormones to Gut Health
Free webinar (5–7PM PT) | Faculty: Michelle Leary ND IFMCP, Denise Furness PhD, Devan Szczepanski MD MS — Register →
|
May 19 — Live webinar: Ferroptosis and chronic disease mechanisms
Free (4PM ET / 1PM PT) | Dr. Kara Fitzgerald with Stephanie Venn-Watson DVM MPH — Register →
|
Jun 16 — Mitochondria Through the Lens of the Gut–Heart–Brain Axis
Free webinar (5–7PM PT) | Faculty: Jeffrey Bland PhD, Sanjay Bhojraj MD, Lisa Portera DC IFMCP — Register →
|
|
Org/Industry Updates
|
CellCore Biosciences has released CoreMend GI, a daily stick-pack powder positioned around five gut restoration pillars: intestinal barrier, mucosal lining, microbiome, gut-immune interface, and gut-brain axis. The formula combines a proprietary prebiotic fiber blend, a probiotic blend, a five-botanical GI lining complex, and CellCore’s BioActive Carbon Technology for delivery and stability. View product →
|
|
Curated weekly for functional nutrition practitioners.
Questions or suggestions? Email hello@nutrishify.com
|
|
Curated weekly for functional nutrition practitioners.
|